Home > Result Summaries: Compounds > Herpes Simplex Vaccine > Result Summary for 208141/039_

Result Summary for 208141/039_

Result Summary

Protocol ID:	208141/039_
Clinical Study ID:	208141/039
Official Title:	A double-blind, randomized, controlled Phase III study to assess the prophylactic efficacy and safety of gD-Alum/MPL vaccine in the prevention of genital herpes disease in young women who are HSV-1 and -2 seronegative.
Phase:	phase 3
Study Indications or Diseases:	Hepatitis A
Generic Name:	Hepatitis A Vaccine, Inactivated
Trade/Product Name:	Havrix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Tavares F et al. (2013) Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit Herpes Simplex Virus vaccine. Vaccine. 31(13):1759-1764. doi: 10.1016/j.vaccine.2013.01.002.